No Data
No Data
2023 equity distribution of Runben Co., Ltd. (603193.SH): $0.17 per share, share registration on May 28
Runben Co., Ltd. (603193.SH) issued the 2023 equity distribution implementation notice. This time, profits are distributed to Israel...
Runben Biotechnology Co., Ltd. (SHSE:603193) Surges 9.2%; Private Companies Who Own 51% Shares Profited Along With Insiders
Key Insights The considerable ownership by private companies in Runben Biotechnology indicates that they collectively have a greater say in management and business strategy 64% of the business is he
Runben Co., Ltd. (603193.SH) reported first-quarter results, net profit of 35.4722 million yuan, an increase of 67.93% over the previous year
Runben Co., Ltd. (603193.SH) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Zhitong A Share Sale Restriction and Release List | April 17
According to the Zhitong Finance App, the ban on restricted shares of 6 listed companies was lifted on April 17, with a total market value of about 4.432 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, restricted stock type, number of banned shares ST Zhongan 600654, share incentives, 159.774, shares, 002843, additional A shares, corporate placement, listing, 375.577 million, Shaanxi Huada 301517 A shares issuer, corporate placement, listing, 1.4446 million, Centai shares 301,429 shares before issuance, limited circulation of 144.811 million Runben shares 603193A shares issuer
Runben Co., Ltd. (603193.SH) will list and circulate approximately 1.825,500 restricted shares on April 17
Runben Co., Ltd. (603193.SH) issued an announcement. The restricted shares currently listed and circulated are the company's initial public offering offline...
Runben Biotechnology Co., Ltd.'s (SHSE:603193) Stock Is Going Strong: Is the Market Following Fundamentals?
Runben Biotechnology (SHSE:603193) has had a great run on the share market with its stock up by a significant 7.4% over the last week. Given the company's impressive performance, we decided to study
No Data